136 related articles for article (PubMed ID: 4150017)
1. The effect of beta-adrenergic blocking agents on the rat adrenal phenylethanolamine-N-methyltransferase activity.
Janiec W; Lukas W; Glogowski A
Pol J Pharmacol Pharm; 1973; 25(3):237-41. PubMed ID: 4150017
[No Abstract] [Full Text] [Related]
2. Effect of beta-adrenergic blocking agents on the spontaneous motility of mice.
Fabian HE; Izquierdo JA
Arzneimittelforschung; 1972 Aug; 22(8):1375-6. PubMed ID: 4404659
[No Abstract] [Full Text] [Related]
3. Importance of the aromatic ring in adrenergic amines. Nonaromatic analoques of phenylethanolamine as substrates for phenylethanolamine N-methyltransferase.
Grunewald GL; Grindel JM; Vincek WC; Borchardt RT
Mol Pharmacol; 1975 Sep; 11(5):694-9. PubMed ID: 1237082
[No Abstract] [Full Text] [Related]
4. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
Kulig A; Kostka-Trabka E; Gryglewski R
Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
[No Abstract] [Full Text] [Related]
5. Position of a chloro substituent on phenylethanolamine as a determinant of methylation by rabbit adrenal norepinephrine N-methyltransferase.
Fuller RW; Hemrick SK; Molloy BB
Res Commun Chem Pathol Pharmacol; 1977 Nov; 18(3):577-80. PubMed ID: 928956
[No Abstract] [Full Text] [Related]
6. Inhibition of brain epinephrine synthesis by 3,4-dichlorophenylethanolamine, a competitive substrate for norepinephrine N-methyltransferase.
Fuller RW; Hemrick-Luecke SK; Perry KW
Biochem Pharmacol; 1983 Jan; 32(2):215-20. PubMed ID: 6870951
[No Abstract] [Full Text] [Related]
7. The binding order of substrates to phenylethanolamine N-methyltransferase.
Pendleton RG; Snow IB
Mol Pharmacol; 1973 Nov; 9(6):718-25. PubMed ID: 4762633
[No Abstract] [Full Text] [Related]
8. The remarkable substrate activity for phenylethanolamine N-methyltransferase of some conformationally defined phenylethylamines lacking a side-chain hydroxyl group. Conformationally defined adrenergic agents. 6.
Rafferty MF; Grunewald GL
Mol Pharmacol; 1982 Jul; 22(1):127-32. PubMed ID: 7121446
[No Abstract] [Full Text] [Related]
9. [Effect of substance P on dopamine-beta-hydroxylase and phenethanolamine-N-methyltransferase in the adrenal glands of rats].
Piesche L; Oehme P; Hilse H; Hecht K
Pharmazie; 1982 Aug; 37(8):591-3. PubMed ID: 6183680
[TBL] [Abstract][Full Text] [Related]
10. Effect of intraperitoneal administration of (+)-INPEA on oxytocin and prostaglandin evoked responses of the isolated rat uterus.
Rao VS; Sharma PL
Br J Pharmacol; 1973 Jun; 48(2):344P-345P. PubMed ID: 4147431
[No Abstract] [Full Text] [Related]
11. Regulation of phenylethanolamine N-methyltransferase synthesis and degradation. I. Regulation by rat adrenal glucocorticoids.
Ciaranello RD
Mol Pharmacol; 1978 May; 14(3):478-89. PubMed ID: 351371
[No Abstract] [Full Text] [Related]
12. Regulation of synthesis and degradation of rat adrenal phenylethanolamine N-methyltransferase. III. Stabilization of PNMT against thermal and tryptic degradation by S-adenosylmethionine.
Berenbeim DM; Wong DL; Masover SJ; Ciaranello RD
Mol Pharmacol; 1979 Sep; 16(2):482-90. PubMed ID: 514254
[No Abstract] [Full Text] [Related]
13. Studies on SK and F 7698; an inhibitor of phenylethanolamine N-methyltransferase (PNMT).
Pendleton RG; Kaiser C; Gessner G; Finlay E; Green H
J Pharmacol Exp Ther; 1974 Sep; 190(3):551-62. PubMed ID: 4415962
[No Abstract] [Full Text] [Related]
14. Methylation of non-phenyl ethanolamines by norepinephrine N-methyltransferase.
Fuller RW; Roush BW
Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):727-30. PubMed ID: 897354
[No Abstract] [Full Text] [Related]
15. Heterogeneity of N-and O-methyltransferases.
Axelrod J; Vesell ES
Mol Pharmacol; 1970 Jan; 6(1):78-84. PubMed ID: 5527525
[No Abstract] [Full Text] [Related]
16. Central actions of some beta-adrenoceptor blocking agents.
Shah UH; Jindal MN; Patel VK; Kelkar VV
Arzneimittelforschung; 1974 Oct; 24(10):1581-4. PubMed ID: 4154760
[No Abstract] [Full Text] [Related]
17. Regulation of phenylethanolamine N-methyltransferase synthesis and degradation. II. Control of the thermal stability of the enzyme by an endogenous stabilizing factor.
Ciaranello RD; Wong DL; Berenbeim DM
Mol Pharmacol; 1978 May; 14(3):490-501. PubMed ID: 207972
[No Abstract] [Full Text] [Related]
18. Catecholamine metabolism in pargyline treated rats exposed to stress.
Prasad R; Patel V; Chansouria JP; Udupa KN
Endocrinol Exp; 1980; 14(2):147-50. PubMed ID: 6104592
[TBL] [Abstract][Full Text] [Related]
19. Comparison of o-octopamine and related phenylethanolamines as substrates for norepinephrine N-methyltransferase.
Fuller RW; Hemrick-Luecke SK; Midgley JM
Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):207-13. PubMed ID: 6795705
[TBL] [Abstract][Full Text] [Related]
20. Substrate and inhibitor kinetics of bovine phenylethanolamine-N-methyltransferase.
Hoffman AR; Ciaranello RD; Axelrod J
Biochem Pharmacol; 1975 Feb; 24(4):544-6. PubMed ID: 1167462
[No Abstract] [Full Text] [Related]
[Next] [New Search]
